Cipro, Levaquin, and Avelox Lawsuit
Cipro, Levaquin, and Avelox Overview
Patients who have suffered from aortic dissection and aneurysm and other aortic problems while taking Cipro, Levaquin, or Avelox may be eligible to pursue a claim and seek financial compensation.
Cipro, Levaquin, and Avelox are antibiotics used for the treatment of a wide variety of serious bacterial infections. They all belong to a class of antibiotics called fluoroquinolones, which is one of the most commonly used antibiotics in the US. They are also meant to be used when first-line antibiotics are not effective.
Studies have suggested that fluoroquinolones are linked with an increased risk of aortic rupture, dissection, and aneurysm, which can lead to hospitalization, surgery, and death. As a result, lawsuits have been filed by patients and surviving family members against manufacturers of the drugs for failing to warn the public about these risks and marketing these fluoroquinolones as first-line antibiotics.
If you or a loved one took Cipro, Levaquin, or Avelox and suffered from aortic rupture and other aortic complications, contact Maxwell Law Group LLP today. We can answer your questions and review your case for free.
Important Note: Maxwell Law Group will no longer be able to accept new Cipro, Levaquin, and Avelox cases.
What are Cipro, Levaquin, and Avelox?
The FDA approved Cipro in 2004 and Avelox in 1999 for manufacturer Bayer Pharmaceuticals. Merck & Co. is a partner co-maker for Avelox. Meanwhile, Levaquin was approved in 1998 for Johnson & Johnson. Bayer and Merck & Co. had $1 billion in sales from Cipro and Avelox, while Johnson & Johnson had $1.3 billion of sales from Levaquin in 2010 alone. It’s estimated that the antibiotic industry will reach $45.09 billion in 2019, with fluoroquinolones having a 16.6% share of the market.
Cipro, Levaquin, and Avelox Quick Facts
How Do Fluoroquinolones Work?
Risks and Warnings
Additional safety communication was released in 2016, specifically regarding the disabling effects of the drug, which can involve the tendons, muscles, joints, nerves, and central nervous system. Fluoroquinolones should be used only in patients with respiratory infections that do not have any alternative options.
The information was updated in 2017, stating that the FDA’s findings on published studies currently do not support reports that fluoroquinolones cause retinal detachment, and aortic rupture, dissection, or aneurysm. However, they will continue to assess safety issues with the drug.
Aortic dissection happens when there is a tear in the inner layer of the aorta, the largest artery of the body. The aorta carries oxygen-rich blood from the heart throughout the body. When this tear reaches the outer layer, it can be potentially fatal. Meanwhile, aortic aneurysm happens when an aortic wall weakens and bulges due to overstretching of the layers. An aneurysm can burst at any time, leading to life-threatening internal bleeding. It usually develops without any symptoms and is difficult to detect.
In 2018, another safety communication was released by the FDA. This safety alert included a warning about blood sugar disturbances and mental side effects caused by fluoroquinolones. The mental side effects included disturbances in attention, disorientation, agitation, nervousness, memory impairment, and delirium.
Injuries from Cipro, Levaquin, and Avelox
Researchers from the University of Massachusetts and Albany Medical College also investigated the relationship of fluoroquinolones and aortic anomalies by doing a review and meta-analysis from Medline, Embase, and Scopus from inception to February 2017. After reviewing 714 citations, evidence from these studies suggests that exposure to these drugs are associated with a significantly increased risk of aortic dissection and aortic aneurysm.
In addition, a study in 2015 from Taiwan examined the link between fluoroquinolone therapy and the risk of developing aortic aneurysm and dissection. An analysis of 1477 patients was observed with data from Taiwan’s National Health Insurance Research Database (NHIRD) from January 2000 through December 2011. Aortic aneurysm was noted in 850 patients, while 662 patients had aortic dissection, and 35 patients were diagnosed with both.
Cipro, Levaquin, and Avelox Lawsuits
How Maxwell Law Group Can Help
You Deserve to be Compensated
We're On Your Side
Our attorneys are always ready to speak with you about your personal situation. Every day we help people in situations similar to yours. Our team can guide you each step of the way and make sure you get the financial compensation you deserve.
While our physical offices are in Utah and Washington DC, we offer our services nationwide. We'd be honored to discuss your case with you free of charge.
Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, don't wait to take action. Contact us today.
To speak with us directly, call (844) 525-7155. We want to hear about your situation and help you through this difficult time.
ATTORNEY ADVERTISING. Nothing on this site should be taken as legal advice for any individual case or situation. This website is not intended to create, and receipt of viewing does not constitute, an attorney-client relationship. Sensitive information should not be submitted through this website as it may be considered confidential or privileged. References to prior results do not guarantee a similar outcome. The firm has attorneys licensed to practice law in Utah and Washington D.C., but the attorneys may also be admitted on an individual basis in additional state and federal courts across the United States. The location of the firm's offices are listed on this website. The firm associates with co-counsel law firms to jointly represent clients in some matters. Gregory Maxwell is the attorney responsible for the contents of this website.